Now in its 7th year, the Inflammasome Therapeutics Summit is the only industry forum focused exclusively on inflammasome-targeted drug development. Join 70+ experts from discovery to clinic, including leading drug developers, translational scientists, and clinical strategists to:

• Share insights and benchmark progress across neuroinflammation, metabolic, and autoimmune indications
• Dive into the latest clinical data, emerging mechanisms, and translational breakthroughs
• Connect with those driving the field forward and shape the next wave of innovation

Join your peers to hear directly from those driving programs forward, tackle the most pressing translational challenges, and help chart the future of inflammasome therapeutics.